Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
284 studies found for:    Primary Lateral Sclerosis
Show Display Options
RSS Create an RSS feed from your search for:
Primary Lateral Sclerosis
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Screening and Natural History: Primary Lateral Sclerosis and Related Disorders
Condition: Primary Lateral Sclerosis
Intervention:
2 Completed Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
Conditions: Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Amyotrophic Lateral Sclerosis
Intervention:
3 Completed Brain Function in Primary Lateral Sclerosis
Condition: Motor Neuron Disease
Intervention:
4 Completed Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis
Condition: Cerebral Cortex Dysfunction
Intervention:
5 Recruiting Use of Dalfampridin in Primary Lateral Sclerosis
Condition: Motor Neuron Disease, Upper
Intervention: Drug: dalfampridine
6 Completed Oxidative Stress in Motor Neuron Disease: COSMOS Add-On Study
Conditions: Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention:
7 Active, not recruiting Imaging Biomarkers in ALS
Conditions: Amyotrophic Lateral Sclerosis;   Primary Lateral Sclerosis
Intervention:
8 Not yet recruiting A Patient Centric Motor Neuron Disease Activities of Daily Living Scale
Conditions: Amyotrophic Lateral Sclerosis;   Progressive Muscular Atrophy;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia
Intervention: Other: Web-based Survey
9 Completed Muscle Ultrasound Measures as Biomarkers of Upper Motor Neuron Function
Condition: Muscle Spasticity
Intervention:
10 Recruiting Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
Intervention:
11 Completed Collection of Blood Samples for DNA in Motor Neuron Disease
Condition: Motor Neuron Diseases
Intervention:
12 Completed Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease
Conditions: Motor Neuron Disease;   Amyotrophic Lateral Sclerosis;   Primary Lateral Sclerosis;   Progressive Muscular Atrophy
Intervention: Biological: Levetiracetam
13 Recruiting Genetics of Familial and Sporadic ALS
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
14 Completed Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
Conditions: Amyotrophic Lateral Sclerosis;   Lou Gehrig's Disease;   Primary Lateral Sclerosis;   Nervous System Diseases;   Hereditary Spastic Paraparesis
Intervention: Other: No intervention
15 Recruiting Genomic Translation for ALS Care
Condition: ALS
Intervention:
16 Recruiting Answer ALS: Individualized Initiative for ALS Discovery
Conditions: Amyotrophic Lateral Sclerosis;   Primary Lateral Sclerosis;   Flail Arm ALS;   Progressive Muscular Atrophy;   Monomelic Amyotrophy;   Motor Neuron Disease;   Asymptomatic ALS Gene Carriers
Intervention:
17 Completed Physiologic Studies of Spasticity
Conditions: Muscle Spasticity;   Healthy
Intervention:
18 Completed A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo;   Drug: 250 mg CK-2017357;   Drug: 500 mg CK-2017357
19 Active, not recruiting Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis
Conditions: Amyotrophic Lateral Sclerosis 1;   Acquired Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis
Intervention: Drug: Arimoclomol
20 Completed Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Olesoxime;   Drug: Placebo Comparator

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.